NCT06646055 2026-03-09
AK112 and Cadonilimab Combined With Chemotherapy for 1L Treatment of Metastatic Pancreatic Cancer
Akeso
Phase 1/2 Active not recruiting
Akeso
University Health Network, Toronto
Thomas Jefferson University
Verastem, Inc.
iOnctura
Biotheus Inc.